Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-03

Clinical Trial Update: A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome

View source ↗

Summary

This clinical trial update describes a non-drug study evaluating the suitability of neurocognitive tests and functioning scales to measure cognitive and functio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Down Syndrome | Status: COMPLETED